| Financial Year |
March 31 2023 |
| Monetary Funds |
744,706,695.03 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
29,783,064.54 |
| Accounts Receivable |
543,149,301.84 |
| Advances to Suppliers |
38,956,424.11 |
| Other Receivables |
141,937,970.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
754,305,214.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
67,751,188.21 |
| Total Current Assets |
2,385,046,965.03 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,249,236.00 |
| Fixed Assetes |
650,622,943.40 |
| Under-construction Projects |
47,814,660.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
110,600,645.24 |
| R&D expenses |
-- |
| Goodwill |
525,537,418.07 |
| Long-Term Deferred and Prepaid Expenses |
11,080,291.39 |
| Deferred Income Tax Assets |
65,464,017.77 |
| Other Non-Current Assets |
38,367,789.27 |
| Sub-Total of Non-Current Assets |
1,519,318,710.15 |
| Total Assets |
3,904,365,675.18 |
| Short-Term Loans |
328,871,814.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
9,169,315.08 |
| Accounts Payable |
280,743,675.21 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
80,924,012.56 |
| Taxes Payable |
23,644,269.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
290,116,828.05 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
17,943,697.89 |
| Other Current Liabilities |
624,147.53 |
| Sub-Total of Current Liabilities |
1,048,011,347.81 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
21,058,800.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
21,818,595.60 |
| Deferred Income Tax Liabilities |
8,129,118.31 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
108,065,736.57 |
| Total Liabilities |
1,156,077,084.38 |
| Paid-In Capital(Or Share Stock) |
420,063,000.00 |
| Capital Surplus |
801,900,064.75 |
| Surplus Reserve |
86,205,765.81 |
| LESS:Treasury Stock |
21,058,800.00 |
| Undistributed Profits |
1,439,054,298.65 |
| Minority Stockholder's Interest |
5,771,120.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,742,517,470.24 |
| Owner's Equity（Stockholder's Equity） |
2,748,288,590.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,904,365,675.18 |
